These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7157232)

  • 21. HUMAN PLASMA TREATED WITH ULTRAVIOLET AND PROPIOLACTONE. SIX-YEAR CLINICAL EVALUATION.
    LOGRIPPO GA; WOLFRAM BR; RUPE CE
    JAMA; 1964 Mar; 187():722-6. PubMed ID: 14094292
    [No Abstract]   [Full Text] [Related]  

  • 22. [Inactivation of hepatitis non-A, non-B virus in intravenous immunoglobulins by beta-propiolactone].
    Dichtelmüller H; Stephan W; Prince AM; Brotman B
    Beitr Infusionsther; 1988; 21():202-4. PubMed ID: 2462976
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biotest position on HIV-1 seroconversions in 1990 in 11 patients, treated with beta-propiolactone/uv virus inactivated PPSB].
    Pustoslemsek P; Kloft M; Kotitschke R
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):344-6. PubMed ID: 8142739
    [No Abstract]   [Full Text] [Related]  

  • 24. A clinical study of the tolerance and safety of a beta-propiolactone-treated immunoglobulin.
    Mondorf AW; Stephan W; Uthemann H; Schuppan D; Lissner R
    Arzneimittelforschung; 1981; 31(11):1928-30. PubMed ID: 6797445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fractionation of cold-sterilized plasma. A new concept in production of non-infectious plasma proteins.
    Stephan W
    Arzneimittelforschung; 1982; 32(8):799-801. PubMed ID: 6890353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A TEN YEAR CLINICAL STUDY OF PLASMA TREATED WITH BETAPRONE AND COMBINED BETAPRONE PLUS ULTRAVIOLET IRRADIATION. COMPARISON WITH PRESENT METHODS OF TREATMENT.
    LOGRIPPO GA
    Pac Med Surg; 1964; 72():298-302. PubMed ID: 14208310
    [No Abstract]   [Full Text] [Related]  

  • 27. Inactivation of the Hutchinson strain of hepatitis non-A, non-B virus in intravenous immunoglobulin by beta-propiolactone.
    Stephan W; Dichtelmüller H; Prince AM; Brotman B; Huima T
    J Med Virol; 1988 Nov; 26(3):227-32. PubMed ID: 3144576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cultivation of mycoplasma in fluid media sterilized with beta-propiolactone].
    Kiuntsel' V; Starost E; Meissner Kh
    Vestn Akad Med Nauk SSSR; 1976; (5):60-2. PubMed ID: 969882
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum hepatitis and the clinical evaluation of blood components sterilized with beta-propiolactone.
    LOGRIPPO GA
    Bibl Haematol; 1962; 13():504-9. PubMed ID: 14466320
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations].
    Stephan W; Dichtelmüller H
    Arzneimittelforschung; 1983; 33(9):1230-1. PubMed ID: 6416260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of beta-propiolactone in blood on routine haematological, biochemical, and serological investigations.
    Freeman R; Codd AA; Selkon JB
    Lancet; 1982 May; 1(8280):1048-9. PubMed ID: 6122856
    [No Abstract]   [Full Text] [Related]  

  • 32. Factor IX concentrate versus prothrombin complex concentrate for the treatment of hemophilia B during surgery.
    Bardin JM; Sultan Y
    Transfusion; 1990 Jun; 30(5):441-3. PubMed ID: 2360238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group.
    Shapiro A; Abe T; Aledort LM; Anderle K; Hilgartner MW; Kunschak M; Preston FE; Rivard GE; Schimpf K
    Transfusion; 1995 Mar; 35(3):204-8. PubMed ID: 7878711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of beta-propiolactone for the sterilization of fermentation media.
    HIMMELFARB P; READ RB; LITSKY W
    Appl Microbiol; 1961 Nov; 9(6):534-7. PubMed ID: 13907502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tolerance of beta-propiolactone-treated and UV-irradiated rat serum].
    Sonneborn HH; Stephan W
    Infusionsther Klin Ernahr; 1980 Jun; 7(3):145-7. PubMed ID: 7191834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of HIV in plasma derivatives by beta-propiolactone and UV irradiation.
    Dichtelmüller H; Stephan W; Prince AM; Gürtler L; Deinhardt F
    Infection; 1987; 15(5):367-9. PubMed ID: 3121517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Destruction of enteric bacteria in liquid egg with beta-propiolactone.
    BRUCH CW; KOESTERER MG
    Appl Microbiol; 1962 Mar; 10(2):123-8. PubMed ID: 13873825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics, thrombogenicity and safety of a double-treated prothrombin complex concentrate.
    Morfini M; Longo G; Berntorp E; Cinotti S; Filimberti E; Messori A; Nilsson IM; Rossi Ferrini P
    Thromb Res; 1993 Aug; 71(3):175-84. PubMed ID: 8211885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of substitution with AT III- and PPSB-concentrates in patients with terminal liver insufficiency].
    Scherer R; Gille A; Erhard J; Paar D; Kox WJ
    Anaesthesist; 1994 Mar; 43(3):178-82. PubMed ID: 8179167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.